Protective role of quercetinum in mercury exposure cardiotoxity

1. Omelchuk ST, Aleksijchuk VD, Sokurenko LM, Blagaia A, Prudchenko S. Characteristics of rat liver exposed to nanoparticles of lead compounds. Georgian Med News. 2016;261:94-9.Search in Google Scholar

2. Omel’chuk ST, Aleksiĭchuk VD, Sokurenko LM. Biochemical parameters of blood and morpho-functional state of the liver of experimental animals by the actions of lead sulfide nanoparticles in different time study. Likars’ka sprava. 2014;3-4:114-8.Search in Google Scholar

3. Busch J. Knödler M, Kühn M, Lipinski A, Steinhoff B. The heavy metals cadmium, lead and mercury in raw materials of animal origin: evaluation of data from practice. Pharmeur Bio Sci Notes. 2015;2015:150-65.Search in Google Scholar

4. Aleksiichuk V, Omelchuk S, Sokurenko L, Kaminsky R, Kovalchuk O, Chaikovsky Y. The influence of lead nanoparticles on the morpho-functional changes of rat liver during the postexposure period. Microsc Res Tech. 2018;81:781-788. doi: 10.1002/jemt.23036.10.1002/jemt.2303629652104Open DOISearch in Google Scholar

5. Lavrinenko VE, Zinabadinova SS, Shobat LB, Sokurenko LM, Chaikovsky YuB. Influence of nanodiamonds and carbon nanowires on survival and cells structure in chicken embryo. Georgian Medical News. 2016;6(255):93-9.Search in Google Scholar

6. Rizzetti, DA, da Silva TM, Escobar AG, et al. Mercury-induced vascular dysfunction is mediated by angiotensin II AT-1 receptor upregulation. Environ Res. 2018;162:287-96, doi: 10.1016/j.envres.2018.01.026.10.1016/j.envres.2018.01.02629407760Open DOISearch in Google Scholar

7. Bernhoft RA. Mercury toxicity and treatment: a review of the literature. J Environ Public Health. 2012;2012: 460508. doi: 10.1155/2012/460508.10.1155/2012/460508325345622235210Open DOISearch in Google Scholar

8. Foras LD. Quercetin in treatment of cardio-vascular diseases. The radical Research. 2005;39:1052-76.Search in Google Scholar

9. Li G, Zhang H, Li Y, Wang Y. Protection of vascular endothelial cells from high glucose injury induced by quercetin. Zhong Yao Cai. 2002;25(4):268-70.Search in Google Scholar

10. Sokurenko LM, Chaikovskii YuB. Mildronate protects neuroblasts against toxic inf luence of mercuric chloride in cell culture. Neurophysiology, 2014;46(3):271-3. https://doi.org/10.1007/s11062-014-9440-710.1007/s11062-014-9440-7Search in Google Scholar

11. Sokurenko LM, Chaikovskii YuB. Protective ef fects of Thiotriazolinum and Mildronate against mercury chloride toxicity in neuroblastoma cell culture Neurophysiology 2016;48(3):171-5. https://doi.org/10.1007/s11062-016-9585-7 . Available from: http://link.springer.com/article/10.1007/s11062-016-9585-710.1007/s11062-016-9585-7Search in Google Scholar

12. Sokurenko LM, Savchyna MO, Litus VI, Kaminsky RF, Сhaikovsky YB. Rat spinal ganglia in assessment of protective action of antioxidants: A morphological study Medicina (Kaunas). 2017;53(4): 217-23. https://doi.org/10.1016/j.medici.2017.11.00110.1016/j.medici.2017.11.00129273287Open DOISearch in Google Scholar

13. Jain AK, Mehra NK, Swarnakar NK. Role of Antioxidants for the Treatment of Cardiovascular Diseases: Challenges and Opportunities. Curr Pharm Des. 2015;21(30):4441-55.10.2174/138161282166615080315175826234792Search in Google Scholar

14. Maksutina NP. Antioxidant Properties of Quercetin. Pharm J. 1993;6:42-3.Search in Google Scholar

15. Pierce E. Histochemistry theoretical and applied. M. Foreign Literature; 1962.Search in Google Scholar

16. Kamynsky R, Primachenko V, Sokurenko L, Chaikovsky Y. A study of impact of mercury chloride on myocardium in experiment. Georgian Med News. 2016;251:64-70.Search in Google Scholar

17. Avtandilov GG. Fundamentals of quantitative pathological anatomy. Moscow, Meditsina Publ, 2002;240 p.Search in Google Scholar

18. Chekman IS. Clinical herbal medicine. Kyiv: Kolos;1993:383.Search in Google Scholar

19. Toronchenko OM, Istomin FM. Application of quercetin in the complex treatment of patients with coronary heart disease with concomitant dyscirculatory encephalopathy. Materials of the III Republican Scientific and Practical Conference «New in Clinical Pharmacology and Pharmacotherapy of Diseases of Internal organs» Kharkiv. 2000;127-9.Search in Google Scholar

20. Ballmann C, Hollinger K, Selsby JT, Amin R, Quindry JC. Histological and biochemical outcomes of cardiac pathology in mdx mice with dietary quercetin enrichment. Exp Physiol. 2015;100(1):12-22.10.1113/expphysiol.2014.08336025557727Search in Google Scholar

21. Dovgan RS, Chekman IS. Morphological changes of hypertension rat myocardium at antihypertensive and metabolic pharmacocorrection. Modern science – moderni veda. 2015;2:168-73.Search in Google Scholar

22. Vatutin NT, Zakhama S. The role of quercetin in preventing the onset of silent myocardial ischemia due to the chronic cardiotoxic effects of anthracycline antibiotics. Questions of Experimental and Clinical Medicine. 2007;11(1):14-8.Search in Google Scholar

23. Kaminsky F. Rostislav, Sokurenko M. Liudmyla, Chaikovsky B. Yuri Status of rats myocardium under subchronic mercury exposure and its pharmacological correction. Curr Issues Pharm Med Sci., 2016;29(4):167-70.10.1515/cipms-2016-0035Search in Google Scholar